Memantine and prevention of worsening in functional communication: post hoc analysis of a randomized, placebo-controlled trial in patients with moderate Alzheimer's disease

被引：0
|
作者：
Graham, S. M. [1 ]
Tocco, M. [1 ]
Hendrix, S. [2 ]
Hofbauer, R. K. [1 ]
Perhach, J. L. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
[2] Pentara Corp, Salt Lake City, UT USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：355 / 355
页数：1
相关论文
共 50 条
  • [11] Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study
    Hager, Klaus
    Baseman, Alan S.
    Nye, Jeffrey S.
    Brashear, H. Robert
    Han, John
    Sano, Mary
    Davis, Bonnie
    Richards, Henry M.
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8 : 1 - 10
  • [12] Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer’s DiseasePost Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
    Stephen Aronson
    Bart Van Baelen
    Shane Kavanagh
    Susanne Schwalen
    Drugs & Aging, 2009, 26 : 231 - 239
  • [13] Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study
    Klaus Hager
    Alan S. Baseman
    Jeffrey S. Nye
    H. Robert Brashear
    John Han
    Mary Sano
    Bonnie Davis
    Henry M. Richards
    Alzheimer's Research & Therapy, 8
  • [14] Memantine Improves Functional Communication in Patients with Moderate to Severe Alzheimer's Disease
    Tariot, Pierre N.
    Saxton, Judith
    Tocco, Michael
    Hofbauer, Robert K.
    Resnick, Malca
    Graham, Stephen M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (03): : A110 - A110
  • [15] Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
    Kishi, Taro
    Matsunaga, Shinji
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2915 - 2922
  • [16] Memantine prevents worsening across multiple domains in a trial of patients with moderate Alzheimer's disease
    Graham, S. M.
    Tocco, M.
    Hendrix, S.
    Hofbauer, R. K.
    Miller, M. L.
    Perhach, J. L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S557 - S557
  • [17] Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial
    Akhondzadeh, S.
    Shafiee-Sabet, M.
    Harirchian, M. H.
    Togha, M.
    Cheraghmakani, H.
    Razeghi, S.
    Hejazi, S. Sh
    Yousefi, M. H.
    Alimardani, R.
    Jamshidi, A.
    Zare, F.
    Moradi, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) : 581 - 588
  • [18] Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
    Herrmann, Nathan
    Ruthirakuhan, Myuri
    Gallagher, Damien
    Verhoeff, Nicolaas Paul L. G.
    Kiss, Alex
    Black, Sandra E.
    Lanctot, Krista L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (11): : 1161 - 1173
  • [19] Efficacy of Memantine ER on Activities of Daily Living: A Post Hoc Responder Analysis From a Randomized Trial in Patients With Moderate-to-severe Alzheimer's Disease
    Alva, Gustavo
    Grossberg, George
    Hendrix, Suzanne
    Ellison, Noel
    Andersen, Kristen A.
    Edwards, John
    NEUROLOGY, 2017, 88
  • [20] Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease: A Pooled Analysis
    Tocco, Michael
    Saxton, Judith
    Hofbauer, Robert K.
    Graham, Stephen M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A78 - A79
12345